CHLORPHENIRAMINE MALEATE 4MG TABLET 4 MG — DIN 02265559
CHLORPHENIRAMINE MALEATE : 4 MG · JAMP PHARMA CORPORATION · TABLET · wholesale supply in Canada
Health Canada status: DORMANT
What is CHLORPHENIRAMINE MALEATE 4MG TABLET?
CHLORPHENIRAMINE MALEATE 4MG TABLET 4 MG contains CHLORPHENIRAMINE MALEATE : 4 MG. It is listed in the Health Canada Drug Product Database under DIN 02265559, held by JAMP PHARMA CORPORATION, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 07-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
Is there a generic Chlorpheniramine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
9 holders have a Canadian DIN containing Chlorpheniramine, across 14 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 1 | 1 | TEVA-PHENIRAM | Sourceable in Canada |
| SCHERING-PLOUGH CANADA INC | 4 | 0 | CHLOR-TRIPOLON DAY AND NIGHT, CHLOR-TRIPOLON NIGHT TIME ALLERGY RELIEF, CHLORTRIPOLON INJ 10MG/ML, CHLORTRIPOLON SYR 2.5MG/5ML | No marketed DIN |
| BAYER INC | 3 | 0 | ALLERGY NITE, CHLOR-TRIPOLON, CHLOR-TRIPOLON 12 HOUR | No marketed DIN |
| BIONATAL DRUG CO | 1 | 0 | CHLORPHENIRAMINE MALEATE TAB 4MG | No marketed DIN |
| EVEREST PHARMACEUTICALS LTD. | 1 | 0 | CHLORPHENIRAMINE MALEATE TAB 4MG | No marketed DIN |
| ICN CANADA LTD. | 1 | 0 | HISTALON TAB 4MG | No marketed DIN |
| JAMP PHARMA CORPORATION | 1 | 0 | CHLORPHENIRAMINE MALEATE 4MG TABLET | No marketed DIN |
| LOGAN PHARMACEUTICALS INC. | 1 | 0 | CHLORPHENIRAMINE TABLETS, 4 MG | No marketed DIN |
| OMEGA LABORATORIES LIMITED | 1 | 0 | CHLORPHENIRAMINE MALEATE INJECTION USP | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 4 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Chlorpheniramine |
|---|---|
| ATC code | R06AB04 |
| AHFS class | 04:04.20 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02265559 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2265559 |
| Brand name | CHLORPHENIRAMINE MALEATE 4MG TABLET |
| Generic / active ingredient | CHLORPHENIRAMINE MALEATE : 4 MG |
| Market authorization holder | JAMP PHARMA CORPORATION |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R06AB04 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R06AB |
| Current status | DORMANT |
| Status date | 07-Aug-2017 |
| Original market date | 2005-02-25 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
1 of 14 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| TEVA-PHENIRAM | 4 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 00021288 |
| ALLERGY NITE | 4 MG | TABLET | BAYER INC | CANCELLED PRE MARKET | 02450453 |
| CHLOR-TRIPOLON | 4 MG | TABLET | BAYER INC | CANCELLED POST MARKET | 00738972 |
| CHLOR-TRIPOLON 12 HOUR | 12 MG | TABLET (EXTENDED-RELEASE) | BAYER INC | CANCELLED POST MARKET | 00738964 |
| CHLOR-TRIPOLON DAY AND NIGHT | 4 MG | TABLET (EXTENDED-RELEASE) ; KIT ; TABLET | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | 02277123 |
| CHLOR-TRIPOLON NIGHT TIME ALLERGY RELIEF | 12 MG | TABLET | SCHERING-PLOUGH CANADA INC | CANCELLED PRE MARKET | 02241291 |
| CHLORPHENIRAMINE MALEATE INJECTION USP | 10 MG | LIQUID | OMEGA LABORATORIES LIMITED | CANCELLED PRE MARKET | 02240953 |
| CHLORPHENIRAMINE MALEATE TAB 4MG | 4 MG | TABLET | EVEREST PHARMACEUTICALS LTD. | CANCELLED POST MARKET | 00490571 |
| CHLORPHENIRAMINE MALEATE TAB 4MG | 4 MG | TABLET | BIONATAL DRUG CO | CANCELLED POST MARKET | 00366706 |
| CHLORPHENIRAMINE TABLETS, 4 MG | 4 MG | TABLET | LOGAN PHARMACEUTICALS INC. | CANCELLED (UNRETURNED ANNUAL) | 02358506 |
2 · Same class — other molecules in ATC R06AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Chlorpheniramine | ALLERGY NITE · CHLOR-TRIPOLON · CHLOR-TRIPOLON 12 HOUR · CHLOR-TRIPOLON DAY AND NIGHT · +9 more | 14 | 1 | Yes |
| Dexchlorpheniramine | POLARAMINE REPETABS 6MG · POLARAMINE TAB 2MG | 2 | 0 | Not in Canada |
| Brompheniramine | DIMETANE TAB 4MG | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R06AA | Clemastine · Dimenhydrinate · Dimenhydrinate, Combinations · Diphenhydramine · Diphenhydramine, Combinations · +3 more | 264 | 76 |
| R06AX | Astemizole · Azatadine · Bilastine · Cyproheptadine · Desloratadine · +6 more | 84 | 38 |
| R06AE | Cetirizine · Cyclizine · Meclozine · Meclozine, Combinations | 69 | 27 |
| R06AD | Alimemazine · Promethazine | 17 | 1 |
| R06AC | Tripelennamine | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is CHLORPHENIRAMINE MALEATE 4MG TABLET called?
The same molecule, Chlorpheniramine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Allergex | Latin | South Africa |
| Chlorhist Syrup | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.